Overview


According to FutureWise analysis the market for diabetes devices in 2023 is US$ 30.27 billion, and is expected to reach US$ 54.87 billion by 2031 at a CAGR of 7.70%.

Blood sugar levels in the body, which result from insulin production, are measured by the devices used in diabetes care. These care solutions are provided to diabetic patients so that they may truly track their blood glucose levels and manage their chronic conditions effectively. Diabetes care tools are frequently used to check the blood glucose levels of diabetics. Throughout the day, diabetes patients' blood glucose levels are recorded and monitored using a continuous glucose monitor (CGM), a medical device.

A diabetic patient's blood glucose level is diagnosed and monitored with diabetes devices. Companies have introduced patient-friendly blood glucose monitoring devices due to the rising demand for minimally intrusive technologies. The number of individuals with diabetes is growing, which has increased the demand for diabetes treatment and devices. Diabetes is very common in the elderly population, which has increased demand for diabetes tracker equipment. The global market for diabetes care devices has also been boosted by government initiatives to raise awareness about diabetes devices. Improvements in the healthcare system and economic expansion are also driving demand for diabetes devices. However, the global market is likely to be constrained by a lack of knowledge about the use of devices in isolated and underdeveloped areas, prolonged registration procedures, and problems with reimbursement. Additionally, companies are concentrating on lowering the price of diabetes care devices, which will probably increase demand.

FutureWise Market Research has published a report that provides an insightful analysis of diabetes device market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, the diabetes device market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • Medtronic plc
  • Abbott Laboratories
  • F.Hoffmann-La-Ltd.
  • Bayer AG
  • Lifescan, Inc.
  • B Braun Melsungen AG
  • Lifescan, Inc.
  • Dexcom Inc.
  • Insulet Corporation
  • Ypsomed Holdings
  • Companion Medical
  • Sanofi
  • Valeritas Holding Inc.
  • Novo Nordisk
  • Arkray, Inc.

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in Diabetes Device Market:

In April 2022- A partnership between Abbott, CamDiab, and Ypsomed was announced in order to create and market an integrated automated insulin delivery (AID) system in European nations. The linked smart wearable device is intended to continuously track a person's blood sugar levels and automatically modify and give the appropriate dose of insulin at the appropriate time, doing away with the need for guessing in insulin dosing.

The most common type of disease, type 2 diabetes, affects more than 31 million Americans, according to the U.S. Centres for Disease Control and Prevention. Being overweight or obese, being over 45, having a close relative with the disease, exercising less than three times per week, and having a history of gestational diabetes (diabetes during pregnancy) are all risk factors for Type 2 diabetes. A heart attack is twice as likely to occur among individuals with Type 2 diabetes as in those without the condition, and it also raises the risk of generating heart disease and stroke. Therefore, it is anticipated that risk factors like smoking, being overweight, obesity, and high cholesterol levels will increase the prevalence of diabetes and increase the demand for diabetes devices. Moreover, the availability of expensive insulin pens and pumps, as well as other technological advancements in diabetic equipment, are increasing the demand for these products. Top manufacturers are focusing on technological developments and the creation of cutting-edge items in order to take a sizable share of the market. A growing number of individuals use blood glucose meters because of their advantages, mobility, and precision. Market players are focusing on the development of these devices and introducing miniature blood glucose meters. Additionally, several government initiatives and public awareness campaigns support market expansion. However, diabetes gadgets don't always provide accurate results. Multiple issues are also preventing the market from expanding. Inconvenient sensor insertions and the challenge of placing multiple devices on small bodies are a couple of such instances. Disruptive alarms also resulted in signal loss, which led to data gaps, skin rashes, adhesion issues, and a proliferation of cumbersome, challenging-to-understand data generated by diabetes care devices.

By Type

  • BGM Devices
    •  Self-Monitoring Devices
      •    Blood Glucose Meters
      •    Testing Strips
      •    Lancets
    •  Continuous Glucose Monitoring Devices
      •    Sensors
      •    Transmitters
      •    Receiver
  • Insulin Delivery Devices
    •  Pumps
    •  Pens
    •  Syringes
    •  Jet Injectors

By Distribution Channel

  • Hospital pharmacies
  • Retail Pharmacies
  • Diabetes Clinics/Centers
  • Online Pharmacies
  • Others

By End-use

  • Hospitals
  • Homecare
  • Diagnostic Centers
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. Along with technical developments and the introduction of new products, the region is anticipated to be driven by the growing prevalence of obesity and the high cost of treatment. The U.S. led the market in North America because of a sizable diabetes population and advantageous reimbursement regulations. Some of the main factors influencing its market include high per capita income and rising healthcare spending.

Additionally based on type; insulin delivery devices registered highest growth in the market. Based on end-user; hospitals dominated the market. Demand for the segment is rising as more diabetic individuals are being admitted to hospitals. Compared to individuals without diabetes, those with diabetes have an increased risk of being hospitalized. In the last few years, technology related to diabetes has advanced quickly. The majority of these innovations aim to enhance the treatment of diabetes in hospitals and clinics. The use of insulin pumps and meters in hospitals and clinics has expanded as a result of these technological developments.


  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the Diabetes Devices Market By Type, By Distribution Channel, By End-use and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Global Diabetes Devices Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Diabetes Devices Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Diabetes Devices Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Diabetes Devices Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. BGM Devices
         1.1. Self-Monitoring Devices
          1.1.1. Blood Glucose Meters
          1.1.2. Testing Strips
          1.1.3. Lancets
         1.2. Continuous Glucose Monitoring Devices
          1.2.1. Sensors
          1.2.2. Transmitters
          1.2.3. Receiver
        2. Insulin Delivery Devices
         2.1. Pumps
         2.2. Pens
         2.3. Syringes
         2.4. Jet Injectors

  • 8.   Global Diabetes Devices Market, By Distribution Channel Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospital pharmacies
        2. Retail Pharmacies
        3. Diabetes Clinics/Centers
        4. Online Pharmacies
        5. Others

  • 9.   Global Diabetes Devices Market, By End-use Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Homecare
        3. Diagnostic Centers

  • 10.   North America Diabetes Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Diabetes Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Diabetes Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Diabetes Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Saudi Arabia
         2.2. UAE
         2.3. South Africa
         2.4. Egypt
        3. Market Size (USD Million) Forecast for MEA  2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Medtronic plc
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Abbott Laboratories
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. F.Hoffmann-La-Ltd.
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Bayer AG
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Lifescan, Inc.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. B Braun Melsungen AG
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Lifescan, Inc.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Dexcom Inc.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Insulet Corporation
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Ypsomed Holdings
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Companion Medical
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Sanofi
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Valeritas Holding Inc.
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. Novo Nordisk
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. Arkray, Inc.
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients